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Abstract  1 
Oxytocin (OXT) has previously been implicated in a range of prosocial behaviors such as 2 
trust and emotion recognition. Nevertheless, recent studies have questioned the evidence for 3 
this link.  In addition, there has been relatively little conclusive research on the effect of OXT 4 
on empathic ability and such studies as there are have not examined the mechanisms through 5 
which OXT might affect empathy, or whether OXT selectively facilitates empathy for 6 
specific emotions. In the current study, we used eye-tracking to assess attention to socially 7 
relevant information while participants viewed dynamic, empathy-inducing video clips, in 8 
which protagonists expressed sadness, happiness, pain or fear. In a double-blind, within-9 
subjects, randomized control trial, 40 healthy male participants received 24 IU intranasal 10 
OXT or placebo in two identical experimental sessions, separated by a 2-week interval. OXT 11 
led to an increase in time spent fixating upon the eye-region of the protagonist’s face across 12 
emotions. OXT also selectively enhanced self-reported affective empathy for fear, but did not 13 
affect cognitive or affective empathy for other emotions. Nevertheless, there was no positive 14 
relationship between eye-gaze patterns and affective empathy, suggesting that although OXT 15 
influences eye-gaze and may enhance affective empathy for fear, these two systems are 16 
independent. Future studies need to further examine the effect of OXT on eye-gaze to fully 17 
ascertain whether this can explain the improvements in emotional behavior. 18 
  19 
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Oxytocin Increases Attention to the Eyes and Selectively Enhances Self-Reported Affective 1 
Empathy for Fear  2 
The ability to understand and share another person’s emotional state or context, 3 
referred to as empathy (Eisenberg & Strayer, 1987), is essential in developing and sustaining 4 
successful reciprocal social relationships (Dziobek et al., 2008). Empathy is a broad 5 
construct, consisting of both cognitive and affective reactions to others’ experiences, and can 6 
be split into two components: cognitive empathy and affective empathy. Cognitive empathy 7 
is the ability to understand what another person is thinking or feeling, whereas affective 8 
empathy involves the vicarious experience of emotions consistent with those of another 9 
(Shamay-Tsoory, 2009). In general, empathy is thought to trigger a number of prosocial 10 
behaviors intended to benefit others. If the other is perceived to be in a negative state, 11 
empathic concern can motivate action and lead to prosocial behavior (de Waal, 2008). 12 
Consequently, these abilities facilitate cooperation and helping behaviors and are considered 13 
important for appropriate moral development (Hoffman, 2000). Conversely, deficient 14 
emotion processing is an important risk factor associated with antisocial behavior and a range 15 
of psychiatric and neurodevelopmental conditions including Autism Spectrum Disorders, 16 
Conduct Disorder and schizophrenia. 17 
Over the last decade, a plethora of studies have implicated the neuropeptide oxytocin 18 
(OXT) in a host of prosocial behaviors, including increased trust (Kosfeld, Heinrichs, Zak, 19 
Fischbacher & Fehr, 2005), generosity (Zak, Stanton & Ahmadi, 2007) and facial emotion 20 
recognition (Domes, Heinrichs, Michel, Berger, & Herpertz, 2007b). Of particular interest to 21 
the current study is the commonly referenced finding concerning the benefits of OXT on 22 
mind-reading (Domes et al., 2007a). These findings have spurred interest in the potential of 23 
OXT to reduce social deficits associated with disorders. 24 
However, some recent studies (e.g., Nave, Camerer & McCullough, 2015; Lane et al., 25 
2015; Radke & de Bruijn, 2015; Hofmann, Fang & Brager, 2016) have failed to replicate 26 
some of the positive effects associated with OXT, raising concerns that previous studies were 27 
underpowered and/or that publication bias has resulted in the selective publication of positive 28 
findings (Lane, Luminet, Nave, & Mikolajczak, 2016). This, combined with some evidence 29 
that OXT can increase negative responses, such as schadenfreude (Shamay-Tsoory, Fischer, 30 
Dvash, Harari, Perach-Bloom & Levkovitz, 2009), has cast doubt on the role of OXT in 31 
promoting prosocial behaviors. As a result, there is a need for further research on the effects 32 
of OXT on prosocial behavior and for closer consideration of the possible mechanisms 33 
through which such effects may occur.  34 
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Given the important role played by empathy in prosocial behavior, it seems logical to 1 
examine whether OXT has an impact on empathy. However, relatively few studies in the 2 
OXT literature have examined the role of OXT in empathy, and those that have done so have 3 
yielded inconsistent results. Using a between-subjects design with 48 healthy male 4 
participants, Hurlemann et al. (2010) examined cognitive and affective empathy using static 5 
pictures depicting people in emotionally charged situations. They found that intranasal OXT 6 
increased affective, but not cognitive empathy in response to both positively and negatively 7 
valenced stimuli. However, Theodoridou, Rowe, and Mohr (2013) found that the self-8 
reported components of affective empathy were unaffected by the administration of OXT, but 9 
that performance on a more implicit measure of cognitive empathy was enhanced following 10 
OXT. It is worth noting that the findings of Hurlemann and colleagues are also inconsistent 11 
with Domes et al.’s (2007) finding that OXT improves cognitive empathy as measured by the 12 
Reading the Mind in the Eye task.  13 
Attempts to replicate these findings have proven unsuccessful, raising doubts about 14 
the effect of OXT on cognitive empathy (Radke & de Bruijn, 2015). Indeed, a recent meta-15 
analysis of 33 studies found that OXT did not significantly influence emotional theory of 16 
mind – a similar construct to cognitive empathy – or the expression of negative emotions in 17 
healthy individuals (Leppanen, Ng, Tchanturia & Treasure, 2017).  A number of studies have 18 
further suggested that OXT only improves cognitive empathy in people who rate themselves 19 
as less socially proficient (Bartz et al., 2010), or who display lower baseline trait empathy 20 
scores (Feeser et al., 2015). Given the large variations in stimuli and methodology in these 21 
studies, it is perhaps not surprising that previous results concerning the effect of OXT on 22 
empathy are inconsistent. 23 
Studies investigating the effects of intranasal OXT on affective empathy are scarce. 24 
This may be due in part to the difficulty in defining this construct, given that it encompasses 25 
both subjective and physiological responses towards other people’s internal states. Apart 26 
from the aforementioned study by Hurlemann et al. (2010), few studies have directly assessed 27 
affective empathy, and those that have done so have tended to focus solely on empathy for 28 
pain. For example, two studies using subjective ratings of responses to painful stimuli found 29 
that OXT did not have a main effect on pain ratings, but did increase ratings as a function of 30 
the perspective (self vs. other) participants were asked to take, or the nationality of the person 31 
with whom to empathize (Abu-Akel, Palgi, Klein, Decety &  Shamay-Tsoory 2015; Shamay-32 
Tsoory et al., 2013). Similarly, in a within-subjects neuroimaging study examining empathy 33 
for a partner’s experience of physical pain, Singer and colleagues (2008) found that OXT 34 
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neither enhanced subjective empathy nor increased activation in empathy-relevant brain areas 1 
such as the anterior insula (AI) and anterior cingulate cortex (ACC). Interestingly, a recent 2 
study found that empathy-related activation in the neural circuitry of pain was strongly 3 
reduced after intranasal OXT, suggesting that OXT might decrease empathy for pain (Bos, 4 
Montoya, Hermans, Keysers, & van Honk, 2015). However, because no behavioural data 5 
were included in this study, further research incorporating behavioural measures is needed in 6 
order to be able to draw firmer conclusions.  7 
 One technique that has the potential to explain any beneficial effects of OXT on 8 
empathy is to use eye-tracking to provide a measure of visual attention allocation. OXT has 9 
been shown to increase gaze toward the eye-region of neutral faces (Guastella, Mitchell, & 10 
Dadds, 2008), and also to increase attention to objects that are the gaze targets of static faces 11 
(Tollenaar, Chatzimanoli, van der Wee, & Putman, 2013). Such findings have led to the 12 
suggestion that OXT might improve prosocial behavior by increasing attention to socially 13 
relevant cues (Guastella et al., 2008). If the administration of OXT alters eye-gaze to 14 
meaningful social information, it is possible that any improvement in prosocial behavior is 15 
via this route. Indeed, within the ASD literature there is evidence that improved facial 16 
emotion recognition is due, in part, to participants spending more time looking at the eye area 17 
of faces (e.g., Andari et al., 2010). Nevertheless, evidence from healthy participants to 18 
support this line of argument is mixed, with one study suggesting that OXT selectively 19 
enhances gaze to the eyes (Auyeung et al. 2015), another showing that OXT results in 20 
increased gaze to the eye areas for positive faces but decreased gaze to the eyes for negative 21 
faces (Domes, Steiner, Porges & Heinrichs, 2013), and others suggesting that improvements 22 
in facial emotion recognition are unaffected by eye-gaze (Hubble et al., 2016; Lischke et al., 23 
2012; ), but instead are related to pupil dilation (Prehn et al., 2013). 24 
To our knowledge, no study to date has examined the effect of OXT on eye-gaze in 25 
relation to empathy. Furthermore, although the use of dynamic stimuli showing characters 26 
experiencing emotions and responding to emotional events is generally considered to provide 27 
a more realistic context in which to measure emotional reactions (Karrow & Connors, 2003), 28 
none of the previous studies examining OXT and empathy used dynamic real-world stimuli. 29 
Similarly, to date the effect of OXT on empathy has only been considered for positively or 30 
negatively valenced emotion (Hurlemann et al., 2010), with the exception of pain (e.g. Singer 31 
et al., 2008). Given that OXT appears to have differential effects in different contexts (e.g., 32 
De Dreu et al., 2010), coupled with evidence suggesting that OXT may have a selective effect 33 
on the processing of fearful facial expressions (Fischer-Shofty, Shamay-Tsoory, Harari & 34 
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Levkovitz, 2010; Leppanen, 2017), it is important to consider the effect of OXT on empathy 1 
for different discrete emotions. These issues are taken into account in the present research. A 2 
further point is that most OXT studies to date have used between-subjects designs. In 3 
response to recent reviews that are critical of the quality and rigor of OXT research 4 
(Churchland & Winkielman, 2012; Leng & Ludwig, 2016; Walum, Waldman, & Young, 5 
2016) and in view of evidence of large variations in individual responsivity to OXT across 6 
participants (Daughters et al., 2015), we decided to study the effects of OXT using a within-7 
subjects design and to take measures of salivary OXT levels to ensure that the nasal sprays 8 
had the intended effect on OXT levels. We also measured eye-gaze during the empathy task, 9 
with a view to explaining any observed effects in terms of attention allocation. 10 
To summarize, there is conflicting evidence for beneficial effects of OXT on both 11 
cognitive and affective empathy. To address these issues, we aimed to measure cognitive and 12 
affective empathy for discrete emotions using a double-blind, within-subjects randomized 13 
control trial of intra-nasally administered OXT. We also explored the mechanism by which 14 
OXT may affect empathy by measuring eye-gaze. To achieve these aims, participants 15 
completed a dynamic empathy task that aimed to evoke empathy experimentally using four 16 
short video clips inducing the emotions of pain, sadness, happiness and fear, during which 17 
participants’ eye-gaze was tracked (van Rijn, Barendse, van Goozen, & Swaab, 2014). After 18 
each clip participants were asked to identify (a) the main character’s emotions and their 19 
intensities, (b) their own emotions and their intensities, and (c) the reasons for the main 20 
character’s and their own emotions.  21 
Consistent with the previously hypothesized prosocial effects of OXT, we predicted 22 
that OXT would enhance both cognitive and affective empathy for all emotions. We also 23 
expected OXT to increase attention to the eye-region of faces and that this increased attention 24 
would be related to greater empathy.  25 
Method 26 
Participants 27 
Forty healthy male students (Mage = 20.98; SD = 4.55) at Cardiff University 28 
participated in this experiment in return for course credit or £40. Participants took part in two 29 
3-hour study sessions, with a 2-week interval between each session (for practical reasons 30 
seven participants had to be tested at later dates; the longest interval between the two sessions 31 
was 35 days). The order in which they received OXT or placebo nasal spray was randomized 32 
and counterbalanced, with researchers and participants remaining blind to this order. The 33 
decision to examine OXT in male participants was taken for two reasons: (1) the effects of 34 
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OXT have been found to differ in males and females, such that collapsing across gender 1 
would not be appropriate (Domes et al., 2010; Kirsch et al., 2005); and (2) administering 2 
OXT to females entails additional ethical and logistical considerations (e.g., controlling for 3 
menstrual cycle phase and/or pregnancy).  4 
Ethical Considerations 5 
The study was approved by both the School of Psychology Ethics Committee at 6 
Cardiff University, and by the Research and Development Office at Cardiff and Vale 7 
University Health Board. Participants were cleared to participate in the study by a medical 8 
professional (co-author AR) and gave written informed consent at each testing session. They 9 
were fully debriefed after the second session. They completed medical pre-screening forms 10 
and signed statements of health before leaving each testing session. All participants had 11 
normal or corrected-to-normal vision, and none of them reported a history of neurological or 12 
mental health disorders, or severe allergic reactions. Participants were asked to refrain from 13 
consuming alcohol in the 24 hours prior to each study session and from smoking cigarettes or 14 
drinking caffeine in the 2 hours prior to each study session. 15 
Measures and Materials 16 
Empathy task: emotion-eliciting video clips. We used eight clips depicting main 17 
characters feeling pain/hurt, sad/upset, fearful/scared or happy/cheerful; these will be referred 18 
to as the pain, sadness, fear and happiness clips, respectively. The clips were edited from 19 
commercially available films or videos and had a duration of approximately 120 seconds. 20 
One set of film clips (i.e., those for pain, sadness, fear and happiness) had previously been 21 
validated (see van Rijn, Barendse, van Goozen, & Swaab, 2014). The current study used four 22 
additional clips, which were selected based on similarity scores from a pilot study to match 23 
the previous set of clips with respect to duration, content and emotional intensity. Participants 24 
viewed one set of four emotional clips during the first visit and the other four clips on the 25 
second visit, and the order of clips was counterbalanced across participants. Clips were 26 
shown to participants using Tobii Studio software on a Dell Precision M4700 laptop with a 27 
15.6 inch screen. 28 
Empathy scores. After each clip participants completed two questionnaires, 29 
indicating how strongly the main character or they experienced each of 10 emotions (labeled 30 
as follows: anger, sad, pain, upset, fearful, happy, scared, cheerful, surprised and hurt). 31 
Ratings were made on a 6-point intensity scale, where 0 indicated no emotion and 5 indicated 32 
intense emotion. Participants were also asked to explain the reason for the emotion(s) they 33 
identified in the main character and in themselves. There were no constraints on the amount 34 
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information they provided. These responses were coded for cognitive and affective empathy 1 
by research assistants who were blind to the participants’ drug condition. Scores took into 2 
consideration four important elements of empathy: (1) whether the target emotion was 3 
correctly identified; (2) whether another, similar emotion was identified; (3) the intensity of 4 
the emotion identified; and (4) the explanation for the causes of the emotion (see van Goozen 5 
et al., 2016). Scores for cognitive empathy ranged from 0-9; a maximum of 2 points was 6 
awarded for identifying the correct target emotion in the main character at the correct 7 
intensity; a maximum of 2 points was also awarded for identifying a relevant similar emotion 8 
at the correct intensity, and up to 5 points were awarded for the participant’s explanation 9 
and understanding of the emotion. For example, an explanation stating “she was scared 10 
because she was slipping and she thought she might fall and die” would receive a maximum 11 
score of 5. Scores for affective empathy ranged from 0-6, where a maximum of 2 points was 12 
awarded for indicating personally feeling the target emotion at a high intensity; another 13 
maximum of 2 points was awarded for indicating personally feeling a relevant similar 14 
emotion at a high intensity, and up to 2 points were awarded for the participant’s explanation 15 
and understanding of their own emotion. For example, an explanation stating “I felt sad 16 
because I thought about that happening to me” would have scored the maximum of 2.  Higher 17 
scores on both scales reflect greater empathy. The measures exhibited satisfactory internal 18 
consistency (Cronbach’s alphas: cognitive empathy = 0.70; affective empathy = 0.83). Inter-19 
rater reliability (Cohen k) between two trained coders on a subset of 10% of the data across 20 
clips ranged from .74 to .82)  21 
 22 
Eye-tracking. Participants were positioned approximately 60-65 cm from a laptop 23 
computer and a 9-point calibration was performed. The quality of calibration was checked; if 24 
there were no data for one or more points, or if calibration quality was poor, calibration at 25 
those points was repeated. This process was completed for a maximum of three calibration 26 
attempts, after which it was unlikely that calibration would improve further. Data from seven 27 
participants were excluded due to poor calibration quality. Calibration was followed 28 
immediately by the empathy stimuli. Eye movements were recorded with a portable Tobii 29 
X2-60 compact eye-tracker sampling at 60Hz with a screen resolution of 1920 x 1080. This 30 
equipment is robust to changes in head position, removing the need for a chin rest. An I-VT 31 
fixation filter with a minimum fixation criterion of 60 milliseconds sampled the average raw 32 
data from both eyes to produce information on eye positions and duration. Eye-gaze validity 33 
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was checked using a sample rate percentage that gives an estimate of the quality of the eye-1 
tracking in a recording by providing a percentage score of successfully-recorded data. One 2 
participant whose validity fell below 70%, meaning eye-tracking data were not available for 3 
more than 30% of the recording, was excluded from the final analysis. For the remaining 4 
participants, validity ranged from 70–97%.  The seven excluded participants did not differ 5 
from those whose eye-tracking data were retained with respect to performance on the 6 
empathy task (overall cognitive empathy: Mincluded = 6.2, Mexcluded = 6.00, p > .05; overall 7 
affective empathy: Mincluded = 3.8, Mexcluded = 3.4, p > .05), age (Mincluded = 21, Mexcluded = 23, p 8 
> .05), or drug order (four of the seven excluded participants received OXT first, the 9 
remaining three received PL first). 10 
 11 
Saliva Samples 12 
Participants produced four saliva samples during each session: at baseline, and 30, 60, 13 
90 min after OXT/placebo administration. These samples were analyzed to measure salivary 14 
OXT at each of these time points. These analyses revealed the OXT nasal sprays were 15 
successful in increasing OXT levels: mean saliva oxytocin concentration (in pg/mL) for all 16 
participants 60 min after administration (during the empathy task) was 952.0 during OXT and 17 
46.4 during PL (see Daughters et al., 2015). When participants excluded from the eye-18 
tracking analysis were removed, mean salivary OXT concentration after 60 min was 826.8 19 
during OXT and 38.4 during PL. There were no significant differences in OXT 20 
concentrations between those included and excluded from the eye-tracking analysis (p > .05). 21 
 22 
Procedure  23 
Participants self-administered 24 IU (three 4IU puffs per nostril) of synthetic OXT or 24 
an independently manufactured placebo nasal spray (PL) that chemically matched the OXT 25 
spray for all compounds, except OXT. Both sprays were manufactured by St Mary’s 26 
Pharmaceutical Unit, Cardiff (http://www.wales.nhs.uk/sites3/home.cfm?orgid=828). A 27 
medical doctor was present during administration, and for the subsequent 15 minutes. A 30-28 
min waiting period was used between drug administration and task start in order to allow the 29 
drug to take effect. This interval was based on previous studies suggesting that OXT 30 
concentrations in both plasma (Gossen et al., 2012) and saliva (Weisman, Zagoory-Sharon & 31 
Feldman, 2012) peak at 30 minutes. This waiting time also ensures that saliva measures 32 
obtained after this point do not reflect spiking due to direct transfer from nose to saliva (for 33 
details, see Martin, Schipper, Verhoef & Merkus, 1998). During the waiting period, 34 
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participants completed a set of measures asking for demographics and food and caffeine 1 
intake. At the end of the waiting period they completed a 15-minute face processing task (see 2 
Hubble et al., 2016), which was followed by the empathy task that started 45 minutes after 3 
OXT administration and lasted approximately 30 minutes. Each video clip was followed 4 
immediately by the empathy questionnaire. In the second session, participants completed the 5 
same empathy task but with different (matched) clip. After completing all tasks, participants 6 
were debriefed about the aims of the study and were asked to indicate which spray they 7 
thought they had during which session and how confident they were of this. Participants 8 
could not accurately report, above chance levels, the session in which they received OXT, (23 9 
guessed correctly) X2(1) = 0.9, p = .34. Furthermore, participants who identified the correct 10 
spray order indicated that they were less certain of that order than those who reported the 11 
incorrect order (Correct M = 3.8; Incorrect M = 5.7), t(38) = 2.35, p = .024.  12 
 13 
Data Analysis 14 
Tobii analysis software was used to analyze eye movements, which allowed areas of 15 
interest (AOI) to be created and a variety of summary reports generated. The eyes were 16 
grouped into one area. A second AOI was created around the mouth. A third AOI was around 17 
the face as a whole to allow for analysis of when participants were looking at the face. Eye-18 
gaze was analyzed during a 4s segment (equivalent to the time-frame given in static emotion 19 
recognition tests) that showed a clear, dynamic development of the emotion. Percentage 20 
dwell time (the sum of the duration of all fixations to an AOI divided by the total duration of 21 
the segment) for each AOI was calculated. The percentage of time spent looking at the eye 22 
and mouth regions was subtracted from that for the whole face to yield a percentage of time 23 
spent looking at the other face areas.  24 
Analyses were carried out using SPSS 20 (SPSS Inc., Chicago, IL). The principal 25 
analyses reported below are analyses of variance. Where the assumption of sphericity was 26 
violated, Greenhouse-Geisser corrections were used. Within each analysis, Bonferroni 27 
corrections were applied for all post-hoc comparisons. Effect sizes were calculated as partial 28 
eta squared (ηp2); small ≥ .01, medium ≥ .06, large ≥ .14; Cohen, 1988). Confidence intervals 29 
have been calculated at the 95% level for the differences of all key findings (CIdiff) and at the 30 
90% level for effect sizes (CIes).   31 
OXYTOCIN, EMPATHY AND EYE-GAZE 11 
 
 
 
Results 1 
Within-subjects ANOVAs were computed, with Drug (OXT or Placebo [PL]) and Emotion 2 
(pain, sadness, fear and happiness) as the within-subject factors. Separate analyses were 3 
carried out on the dependent variables of cognitive empathy and affective empathy.  4 
 5 
Cognitive Empathy  6 
Mean cognitive empathy scores are shown in Figure 1. Results revealed a significant 7 
main effect of Emotion, F(3, 117) = 12.93, p < .001, ηp2 = .25, but no main effect of Drug, 8 
F(1, 39) = 0.04, p = .84, ηp2 = .00, and no interaction between Drug and Emotion, F(3, 117) = 9 
2.14, p = .10, ηp2 = .05. Follow-up analyses revealed that cognitive empathy for pain (M = 10 
6.4, SD=0.7), and fear (M = 6.5, SD = 0.9) were similar (p > .05) and significantly higher 11 
than those for sadness (M = 5.9, SD = 0.7) and happiness (M = 5.9, SD = 0.8) (all ps <.05) 12 
which did not differ (p > .05). 13 
INSERT FIGURE 1 HERE 14 
Affective Empathy 15 
Mean affective empathy scores are shown in Figure 2. There was a main effect of 16 
Emotion, F(3, 117) = 16.03, p <.001, ηp2  = .29. Affective empathy was significantly greater 17 
for sadness (M = 4.6, SD = 0.9) compared to pain, happiness and fear (all ps < .001), and 18 
there were no significant differences in affective empathy between fear (M = 3.5, SD = 1.6), 19 
pain (M = 3.4, SD = 1.3) and happiness (M = 3.5, SD = 1.0) (all ps > .05). There was no main 20 
effect of Drug, F(1, 39) = 0.13, p = .73, ηp2 = .00, but there was a significant interaction 21 
between Emotion and Drug, F(3, 117) = 2.77, p = .045, ηp2 = .06, 90% CIes [.001, .13]. 22 
Affective empathy for fear was significantly higher (p = .02, ηp2 =.14, 90% CIes [.02, .31], in 23 
the OXT (M = 3.9, SD = 1.7) than PL (M = 3.2, SD = 1.8) condition (95% CIdiff [0.1, 1.1]). 24 
The corresponding differences were not significant for pain (p = 1.00), happiness (p = .25) or 25 
sadness (p = .35).  26 
INSERT FIGURE 2 HERE 27 
Eye-gaze Patterns 28 
An ANOVA was conducted with three within-subjects factors: Drug (OXT vs PL), 29 
Emotional Clip (Pain, Happiness, Sadness, or Fear) and AOI (Eye, Mouth, or Rest of face). 30 
There was a main effect of AOI, F(1.31, 41.95) = 35.58, p < .001, ηp2 = .53, reflecting the fact 31 
that percentage dwell time to the eye-region was greatest (M = 36%, SD = 15.1), followed by 32 
that for the rest of the face (M = 29%, SD = 7.6);  dwell time to the mouth region was 33 
significantly lower than both the eye-region (p < .001) and the rest of the face (p < .001) (M = 34 
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11%, SD = 8.2). Dwell times for the eye-region and the rest of the face did not significantly 1 
differ from each other (p = .13). 2 
 A significant main effect of Emotion, F(2.49, 79.6) = 25.81, p < .001, ηp2 = .45, 3 
showed that participants spent significantly more time looking at the face of the main 4 
character during the sadness clip (M = 30%, SD = 4.3), compared to the happiness (M = 26%, 5 
SD = 4.3) pain (M = 24%, SD = 5.2) and fear (M = 21.2%, SD = 5.5) clips (all ps < .05). 6 
There was no significant difference in dwell time for the face when watching the happiness 7 
and pain clips (p = .33) but during the fear clip participants spent significantly less time 8 
looking at the face compared to the other clips (all ps <.05). The main effect of Drug was 9 
marginal, F(1, 32) = 3.76, p = .06, ηp2 = .11, and reflected the fact that participants in the PL 10 
condition tended to spend more time looking at the face in general (M = 26%, SD = 3.3) 11 
compared to the OXT condition (M = 25%, SD = 4.4). The Emotion by Drug interaction was 12 
not significant, F(2.29, 73.2) = .05, p = .99, ηp2 = .00. 13 
The three-way interaction between Drug, Emotion and AOI was not significant, 14 
F(4.53 144.79) = 0.68, p = .62, ηp2 = .02, but there were significant interactions between Drug 15 
and AOI, F(2, 64) = 10.71, p < .001, ηp2 = .25, 90% CIes [.09, .37]  and between Emotion and 16 
AOI, F(3.72, 118.96) = 20.2, p < .001, ηp2 = .39, 90% CIes [.26, .47] Means relevant to the 17 
Drug by AOI interaction are shown in Figure 3. Follow-up tests revealed that OXT resulted 18 
in a greater proportion of time fixating on the eye-region, F(2, 96) = 11.33, p = .002, ηp2 = 19 
.26, 90% CIes [.08, .29], 95% CIdiff [2.7, 10.9]; given this, it is not surprising that OXT also 20 
led to less time spent looking at the mouth, F(2, 96) = 3.73, p = .06, ηp2 = .10, 90% CIes [.004, 21 
.15], 95% CIdiff [-7.2, 0.2], and the rest of the face, F(2, 96) = 12.86, p = .001, ηp2 = .29, 90% 22 
CIes [.09, .30}, 95% CIdiff [-11.8, -3.2]. 23 
 24 
INSERT FIGURE 3 HERE 25 
 26 
Means relevant to the Emotion by AOI interaction are shown in Figure 4. Follow-up 27 
tests revealed that there were significant differences between the clips in the proportion of 28 
time spent fixating upon the eyes, F(4, 119) = 34.05, p < .001, ηp2 = .77, and mouth, F(4, 119) 29 
= 21.29, p < .001, ηp2 = .68. Further analyses revealed that participants spent a significantly 30 
greater proportion of time fixating on the eyes during the sadness clip compared to the 31 
happiness, fear and pain clips (all ps < .05), whereas a significantly greater proportion of time 32 
was spent looking at the mouth during the pain clip compared to the happiness, sadness and 33 
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fear clips (all ps < .05). There were no differences between clips with respect to the amount 1 
of time spent fixating upon the rest of the face, F(4, 119) = 0.98, p = .41, ηp2 = .09. 2 
 3 
INSERT FIGURE 4 HERE 4 
Comparing Empathy and AOI 5 
To examine the relationship between eye-gaze and empathy, we calculated 6 
Spearman’s rhos to assess the association between changes in cognitive empathy and 7 
affective empathy scores from PL to OXT for each emotional clip and the change in dwell 8 
time to the eye-region from PL to OXT for the same clip (difference scores were calculated 9 
as OXT – PL for each variable). As can be seen in Table 1, there was a significant inverse 10 
correlation between affective empathy for fear and dwell time to the eye-region (p < .05).  11 
INSERT TABLE 1 HERE 12 
 13 
Discussion 14 
We set out to establish whether OXT affects self-reported empathy and whether any 15 
changes in empathy are associated with altered eye-gaze to socially relevant stimuli. In 16 
contrast to our hypothesis, which predicted that OXT would result in enhanced cognitive and 17 
affective empathy across all emotions, our results demonstrate that a single dose of OXT 18 
administered to healthy male subjects enhanced their ability to empathize affectively with a 19 
fearful protagonist, but not with a protagonist displaying pain, sadness or happiness. This is 20 
inconsistent with the findings from Domes et al. (2007) who found that OXT improved 21 
cognitive empathy. However, our findings are partly consistent with evidence from 22 
Hurlemann et al. (2010), who found that OXT increased affective but not cognitive empathy, 23 
although these authors found increased affective empathy for both positively and negatively 24 
valenced stimuli. A possible reason for this discrepancy in findings is that the empathy-25 
inducing stimuli differed between the two studies. Hurlemann et al. used static photos, 26 
whereas we used dynamic clips.  Dynamic clips are arguably of greater ecological validity, in 27 
that they reflect more closely the kind of everyday interpersonal interaction in which an 28 
empathic response could be aroused (Karrow & Connors, 2003). An additional strength of the 29 
present study is the use of a within-subjects design, which controls for the sizeable individual 30 
differences that arise in response to intranasally administered OXT (Daughters et al., 2015). 31 
The selective effect of OXT on fear observed in the present study is consistent with 32 
findings from research exploring the effect of OXT on facial emotion recognition. Fischer-33 
Shofty et al. (2010), also employing dynamic video clips of emotional facial expressions, 34 
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found that OXT selectively enhanced recognition only for fearful faces. In a recent meta-1 
analysis of 9 studies investigating the effects of intranasal OXT on the recognition of fear 2 
(two of which included people with schizophrenia and borderline personality disorder), 3 
Leppanen et al. (2017) concluded that OXT significantly improved the recognition of basic 4 
emotions, albeit with a small effect size, and that the effect is robust, with no evidence of 5 
publication bias. However, it was only reliable for healthy individuals. OXT has also been 6 
found to increase attention and approach towards fearful facial expressions (Clark-Elford et 7 
al., 2015; Tollenaar et al., 2013). In a further meta-analysis, Leppanen, Ng, Kim, Tchanturia, 8 
and Treasure, (2018) found that OXT significantly increased the physiological startle 9 
response to threat in healthy participants, but did not increase fixations to threatening stimuli. 10 
Thus the present findings are consistent with evidence that OXT influences the salience of 11 
threatening stimuli. 12 
Interestingly, neuroimaging evidence suggests that the administration of OXT inhibits 13 
amygdala activation (Domes et al., 2007b; Kirsch et al., 2005; Singer et al., 2008), thereby 14 
dampening the fear response, which appears to be inconsistent with the improvement in fear 15 
recognition observed by Fischer-Shofty et al. (2010) and with the greater affective empathy 16 
for fear responses observed in the present research. Given that there are a number of brain 17 
areas associated with the processing of fearful stimuli and affective empathy, and that OXT 18 
binding sites have been observed in different areas of the rats brain that are involved in 19 
emotion processing (Febo, Numan & Ferris, 2005; Ferris, 2008; Smeltzer, Cutis, Aragona & 20 
Wang, 2006), it is possible that OXT modulates different cortical regions that are important 21 
for processing threatening stimuli, and thereby improves affective empathy for fear (Fischer-22 
Shofty et al., 2010). 23 
A strength of the present study is the use of eye-tracking technology to investigate 24 
whether any improvement in empathy resulting from OXT was matched by increased 25 
attention to socially relevant stimuli. We found that OXT led to a general increase in the 26 
amount of time participants fixated on the eye-region of the face for four different types of 27 
emotion. These results contrast with those reported by Lischke et al. (2012), who found no 28 
evidence that OXT altered eye-gaze in healthy participants. Nevertheless, our results are 29 
consistent with evidence from ASD literature suggesting that OXT increases attention to 30 
socially relevant stimuli, and specifically for the eye-region (e.g., Andari et al., 2010).  31 
ASD researchers have argued that improvements in facial emotion recognition 32 
associated with OXT administration result from increased attention to the eye-region, 33 
although few studies have empirically tested this notion. With respect to empathy research, 34 
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no prior study has examined eye-gaze as a possible mediator of enhanced empathy.  We 1 
found no evidence that changes in eye-gaze resulting from OXT were related to greater 2 
empathy. Thus the observed increase in affective empathy for fear did not result from 3 
increased attention to socially relevant stimuli. Indeed, improved empathy for fear was 4 
associated with a reduced time looking at the eye region, a pattern that was also evident for 5 
other emotions, albeit to a lesser extent. Given the relatively small sample size in this study, 6 
further research is needed to establish the reliability of this finding. If replicated, it may 7 
reflect an attempt by participants who are empathizing more strongly with the protagonist’s 8 
fear to regulate their own emotions by looking less at the protagonist’s eyes.  9 
 A possible explanation for absence of a strong link between emotional responding 10 
and eye gaze concerns the stimuli used. Evidence for a link between emotion recognition and 11 
eye-gaze has typically been found in studies using images where the only basis for judgments 12 
is provided by facial features. The emotional stimuli used in the current study depicted 13 
protagonists experiencing emotions in arousing situations. Participants therefore had access 14 
to non-facial cues, such as tone of voice, gestures and contextual information. This may have 15 
rendered information from the face less important. However, we do not regard this as a 16 
limitation, because dynamic stimuli showing people responding to emotional situations is 17 
more reflective of everyday occurrences; instead, the results suggest that eye-gaze may be 18 
less important in everyday interactions than it is in studies simply investigating responses to 19 
facial images. It is worth noting that in a separate task, using the same group of participants 20 
but static facial expressions, OXT did not result in significant changes in eye-gaze (Hubble et 21 
al., 2016), which also suggests that the dynamic nature of the stimulus was important in the 22 
current finding.  23 
Another possible reason for the absence of a strong relationship between eye-gaze and 24 
empathy concerns the timing of the measures. Affective empathy was measured after each 25 
clip, requiring participants to integrate their emotional experiences during the 2-min stimulus 26 
into a single score, whereas the eye-gaze data were collected during a 4-sec segment of each 27 
clip that showed a clear, dynamic development of the emotion. Comparing strictly 28 
contemporaneous eye-gaze and empathy data might reveal a stronger relationship between 29 
them, although this would be very difficult to implement, given that providing continuous 30 
ratings of emotions (one’s own or another’s) would likely interfere with eye-tracking 31 
analysis. Physiological measures therefore offer a better way of comparing eye-gaze and 32 
empathy continuously, although but they are affected by other issues (e.g., they reflect 33 
arousal but are relatively insensitive to valence; see Lang, Greenwald, Bradley & Hamm, 34 
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1993). Given the evidence that OXT may be especially involved in the initial allocation of 1 
attentional resources (Gamer, Zurowski & Buchel, 2010), future studies could consider 2 
whether monitoring early fixations would result in a stronger relation between eye-gaze and 3 
empathy.  4 
Limitations 5 
Our conclusions concerning the possible role of OXT on affective empathy for fear 6 
and eye-gaze derive from an exogenous administration study, in which participants received 7 
intranasal OXT or a matching PL. This method has the advantage of being able to draw 8 
conclusions about cause and effect relationships, which would not be possible if one were 9 
correlating endogenous oxytocin with empathy or eye-gaze. The disadvantage of this method, 10 
however, is that the pathways through which intranasal OXT affects brain activity and 11 
behavioral responses are not fully understood (e.g., McCullough, Churchland, & Mendez, 12 
2013). Although there is good evidence that intranasal OXT increases the concentration of 13 
endogenous OXT found in blood plasma and saliva (Daughters et al., 2015; Gossen et al., 14 
2012; Weisman et al., 2012), doubt has been cast on the extent to which intranasal OXT 15 
crosses the blood-brain barrier (Neumann et al., 2013; Paloyelis et al., 2014; Striepens et al., 16 
2013). Walum et al. (2016) also raised concerns about the power of OXT studies, suggesting 17 
that a sample size of more than 300 participants is needed to achieve sufficient power, 18 
compared to the average of 49 participants (between-subjects) used in previous studies. 19 
Although nowhere near the size proposed by Walum et al., our study represents an 20 
improvement on many previous studies, especially given that it benefitted from the use of a 21 
within-subject design. We were also able to confirm that OXT levels were higher in the OXT 22 
condition, thereby mitigating some of the concerns associated with exogenous administration 23 
of OXT. Nevertheless, we acknowledge that the results from this study would benefit from 24 
replication with larger samples.  25 
A further limitation of the present study stems from the fact that our measure of 26 
affective empathy depended on self-reports of emotion. Self-reported emotional states can be 27 
confounded by conscious awareness of the response or even the willingness to report this 28 
response. They are also vulnerable to demand characteristics and social desirability (e.g., 29 
Eisenberg-Berg & Hand, 1979). Consequently, self-reports might not necessarily reflect how 30 
the individual actually felt, but rather indicate perceptions of how other people expect one to 31 
feel. Physiological measurements, such as skin conductance or facial responsivity can help to 32 
overcome some of these pitfalls. For example, Korb et al. (2016), used facial EMG to show 33 
that facial mimicry increased during OXT, particularly in response to angry infant faces. 34 
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Nevertheless, physiological measures also have limitations; for example, they do not 1 
distinguish between empathy, sympathy and personal distress (Zhou, Valiente & Eisenberg, 2 
2003).  3 
The limitations associated with particular measures of affective empathy suggest that 4 
no single measurement is perfect. Studies examining the convergence between different 5 
measures of affective empathy show that some measurements, such as self-report measures 6 
and facial responsiveness, correlate with each other (Anastassiou-Hadjicharalambous & 7 
Warden, 2007), suggesting there is a common construct that is tapped by each measure. This 8 
points to the importance of measuring affective empathy using a multi-method approach to 9 
examine whether OXT enhances different components of affective empathy. Indeed, 10 
evidence from studies examining the effect of OXT on facial emotion recognition (Prehn et 11 
al., 2015) suggests examining pupil dilation in response to empathy could be a worthwhile 12 
next step. 13 
A final limitation is that we examined the effects of OXT in a male-only sample. This 14 
arose from the practical and ethical complications entailed in administering OXT to women. 15 
Evidence suggests that there are sex differences in empathic abilities (e.g., Baron-Cohen & 16 
Wheelwright, 2004) and that OXT differentially modulates the neural circuitry involved in 17 
face processing in men and women. For example, while it has been demonstrated that OXT 18 
decreases amygdala activity in response to fear in men (Kirsch et al., 2005), it appears to 19 
increase amygdala activity to similar stimuli in women (Domes et al., 2010). Additionally, 20 
women typically report higher levels of affective empathy than men (Hurlemann et al., 2010; 21 
Theodoridou et al., 2013). Our results may therefore not be generalizable to women. In 22 
addition, given that our sample were all undergraduates who tend to perform reasonably well 23 
in these types of tasks, it is possible that our results may not be generalizable to populations 24 
who might find these tasks more challenging. It is worth noting that OXT has been found to 25 
have stronger effects when task difficulty is higher (Domes et al., 2007a; Feeser et al., 2015), 26 
suggesting the effect of OXT on empathy may be greater in populations showing empathy 27 
deficits (Feeser et al., 2015).  28 
Conclusion 29 
The present results suggest that the administration of OXT selectively enhances affective 30 
empathy for fear, whilst leaving cognitive empathy and affective empathy for sadness, 31 
happiness and pain unaffected. Furthermore, we show for the first time using an emotion-32 
inducing film clip paradigm that OXT significantly increased gaze towards the eye-region of 33 
faces across the four emotions studied here. However, increased dwell time for the eyes was 34 
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not positively related to affective empathy for fear, suggesting that the widely held, but rarely 1 
tested, notion that OXT-induced effects on emotional responding result from increased 2 
attention to socially relevant stimuli is in need of closer scrutiny.   3 
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 1 
Table 1 2 
Intercorrelations (Spearman’s rho) between the difference in affective and cognitive empathy 3 
scores between OXT and PL conditions for each clip and the difference in eye-region dwell 4 
times for OXT and PL conditions for each clip 5 
Affective 
Empathy 
Eye-region 
dwell time 
N=33 
Cognitive 
Empathy 
Eye-region 
dwell time 
N=33 
Pain -.06 Pain -.29 
Happiness .06 Happiness .002 
Sadness .16 Sadness .13 
Fear -.43* Fear -.33+  
* =  p <.05, + = .058 6 
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 10 
 11 
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 17 
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 24 
 25 
 26 
OXYTOCIN ENHANCES EMPATHY AND EYE-GAZE 29  
 
 
 
 1 
Figure 1: Cognitive empathy as a function of emotional clip and drug. Error bars show +2 SE 2 
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  1 
Figure 2. Affective empathy as a function of emotional clip and drug. Error bars show +2 SE. 2 
*p < .05 3 
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 1 
Figure 3: Percentage dwell time as a function of area of interest and drug. Error bars show +2 2 
SE. +p < .10, *p < .05 3 
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 1 
Figure 4:  Percentage dwell time as a function of area of interest and emotion. Error bars 2 
show +2 SE. *p < .05 3 
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